GW&K Investment Management LLC Has $57.45 Million Holdings in Integer Holdings Co. (NYSE:ITGR)

GW&K Investment Management LLC lessened its position in shares of Integer Holdings Co. (NYSE:ITGR) by 17.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 433,531 shares of the medical equipment provider’s stock after selling 88,600 shares during the period. GW&K Investment Management LLC’s holdings in Integer were worth $57,452,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Loomis Sayles & Co. L P lifted its holdings in shares of Integer by 3.0% during the third quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider’s stock worth $69,943,000 after buying an additional 15,446 shares in the last quarter. Jane Street Group LLC increased its stake in shares of Integer by 23.3% in the 3rd quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider’s stock valued at $19,682,000 after purchasing an additional 28,572 shares during the last quarter. Verition Fund Management LLC raised its holdings in shares of Integer by 17.4% during the 3rd quarter. Verition Fund Management LLC now owns 3,470 shares of the medical equipment provider’s stock worth $451,000 after buying an additional 515 shares in the last quarter. Versant Capital Management Inc lifted its position in shares of Integer by 98.4% during the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock worth $49,000 after buying an additional 183 shares during the last quarter. Finally, KBC Group NV boosted its stake in Integer by 83.3% in the fourth quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider’s stock valued at $212,000 after buying an additional 726 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

Wall Street Analysts Forecast Growth

ITGR has been the subject of a number of research reports. Citigroup increased their target price on shares of Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a report on Wednesday, December 11th. KeyCorp boosted their target price on shares of Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Truist Financial increased their price target on Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Benchmark raised their price objective on Integer from $140.00 to $150.00 and gave the company a “buy” rating in a report on Friday, February 21st. Finally, Oppenheimer cut Integer from an “outperform” rating to a “market perform” rating in a report on Friday, February 21st. Two equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $147.67.

Integer Stock Performance

NYSE ITGR opened at $124.00 on Friday. The company has a market capitalization of $4.17 billion, a price-to-earnings ratio of 36.91, a PEG ratio of 1.72 and a beta of 1.13. Integer Holdings Co. has a twelve month low of $105.14 and a twelve month high of $146.36. The stock has a fifty day simple moving average of $137.06 and a 200 day simple moving average of $132.78. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). The company had revenue of $449.50 million for the quarter, compared to the consensus estimate of $446.28 million. Integer had a return on equity of 11.65% and a net margin of 6.92%. Sell-side analysts expect that Integer Holdings Co. will post 6.01 EPS for the current year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.